Form 4 Filing: Fischer Laurent Acquires (Grant) shares of $LYCA

STOCK AWARD / GRANT

⚡ MATERIALITY: 1/10

corporate issuer

Lycia Therapeutics, Inc.

Ticker: $LYCA

Transaction Value

N/A (Non-Open-Market)

Price/Share: $0.00 (Non-Open-Market)

transaction date

2026-08-11

Shares: 33,307

Market Price Activity

HillSignal AI Analytical Report

SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Fischer Laurent, holds the title of Director at Lycia Therapeutics, Inc..

On 2026-08-11, the insider transacted 33,307 shares.This transaction is a non-open-market event (such as a stock grant or option exercise) with a reported price per share of $0.00.

Executive Summary Summary

Fischer Laurent (Director) was granted $0 of $LYCA

Post-Transaction Position: 13,307 shares

SEC Accession No: 0001379344-26-000011 (CIK: 1379344)

Verified Multi-Source Index

Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.

SEC EDGAR FilingView Source Form 4

Yahoo Finance$LYCA Quote & Profile

OpenCorporates RegistryVerify Corporate Identity

Google News$LYCA News Coverage